GM2 Gangliosidosis with Hexosaminidase A and B Defect: Report of a Family with Motor Neuron Disease-like Phenotype

  • A. Federico
  • G. Ciacci
  • I. D’Amore
  • R. Pallini
  • S. Palmeri
  • A. Rossi
  • N. Rizzuto
  • G. C. Guazzi

Abstract

GM2 Gangliosidosis is an inherited dysmetabolic disease, characterized by accumulation of GM2 and GA2 gangliosides in neuronal as well as in non-neuronal tissues. Biochemically the disorder can be due either to a deficiency of hexosaminidase isoenzyme A (Tay-Sachs form) or isoenzymes A and B (Sandhoff variant) or to absence of the activator protein of the enzyme (Sandhoff and Christomanov, 1979). Infantile, juvenile and adult phenotypes are known. Recently patients with late-onset disease with amyotrophic lateral sclerosis-like or Kugebelg-Welander phenotypes or spinocerebellar ataxia have been described, and a large heterogeneity is increasingly being discovered (Johnson, 1981; Federico, in press).

Keywords

Amyotrophic Lateral Sclerosis Cerebellar Ataxia Motor Neuron Disease Spinocerebellar Ataxia Motor Nerve Conduction Velocity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Argov, Z., Navon, R. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency. Ann. Neurol. 16 (1984) 14–20PubMedCrossRefGoogle Scholar
  2. Barbeau, A., Plasse, L., Cloutier, T., Paris, S., Roy, M. Lysosomal enzymes in ataxia: discovery of two cases of late-onset hexosaminidase A and B deficiency (adult Sandoff disease) in French Canadians. Canad. J. Neurol. Sci. 11 (1984) 601–606PubMedGoogle Scholar
  3. Conzelman, E., Sandhoff, K. Partial enzyme deficiencies: residual activities and the development of neurologic disorders. Dev. Neurosci. 6 (1984) 58–71CrossRefGoogle Scholar
  4. Conzelman, E., Sandhoff, K. Partial enzyme deficiencies: residual activities and the development of neurologic disorders. Dev. Neurosci. 6 (1984) 58–71CrossRefGoogle Scholar
  5. Guazzi, G. C., Rizzuto, N., Ciacci, G., D’Amore, I., Rossi, A. Polyneuritiform spinocerebellar ataxia with dominant autosomic transmission. Neuropath. Acta Neurol. 5 (1983) 303–304Google Scholar
  6. Johnson, W. G. The clinical spectrum of hexosaminidase deficiency diseases. Neurology 31 (1981) 1453–1456PubMedGoogle Scholar
  7. Johnson, W. G. Genetic heterogeneity of the hexosaminidase deficiency diseases. In Kety, S., Rowland, L. P., Sidman, R. L., Matthysse, S. W. (eds.) Genetics of Neurological and Psychiatric Disorders, Raven Press, New York, 1983, pp. 215–237Google Scholar
  8. Sandhoff, K., Christomanov, H. Biochemistry and genetics of gangliosidoses. Hum. Genet. 50 (1979) 107–147PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and MTP Press Limited 1986

Authors and Affiliations

  • A. Federico
    • 1
  • G. Ciacci
    • 1
  • I. D’Amore
    • 1
  • R. Pallini
    • 1
  • S. Palmeri
    • 1
  • A. Rossi
    • 1
  • N. Rizzuto
    • 2
  • G. C. Guazzi
    • 1
  1. 1.Istituto di Scienze Neurologiche e Centro per lo studio delle Encefalo-neuro-miopatie genetichedell’Università di SienaSienaItaly
  2. 2.Cattedra di NeuropatologiaUniversità di VeronaItaly

Personalised recommendations